Symbicort and Trigeminal neuralgia - a phase IV clinical study of FDA data


Trigeminal neuralgia is found among people who take Symbicort, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Symbicort and have Trigeminal neuralgia. It is created by eHealthMe based on reports of 97,511 people who have side effects when taking Symbicort from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 24, 2022

97,511 people reported to have side effects when taking Symbicort.
Among them, 47 people (0.05%) have Trigeminal neuralgia.

What is Symbicort?

Symbicort has active ingredients of budesonide; formoterol fumarate dihydrate. It is often used in asthma. eHealthMe is studying from 99,472 Symbicort users for its effectiveness, alternative drugs and more.

What is Trigeminal neuralgia?

Trigeminal neuralgia (a painful condition of the nerve responsible for most facial sensation) is found to be associated with 1,066 drugs and 655 conditions by eHealthMe.

Number of Symbicort and Trigeminal neuralgia reports submitted per year:

Could Symbicort cause Trigeminal neuralgia?

Time on Symbicort when people have Trigeminal neuralgia *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Trigeminal neuralgia when taking Symbicort *:

  • female: 81.4 %
  • male: 18.6 %

Age of people who have Trigeminal neuralgia when taking Symbicort *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 2.63 %
  • 20-29: 0.0 %
  • 30-39: 26.32 %
  • 40-49: 5.26 %
  • 50-59: 13.16 %
  • 60+: 52.63 %

Common drugs people take besides Symbicort *:

  1. Lyrica: 15 people, 31.91%
  2. Singulair: 13 people, 27.66%
  3. Zantac: 11 people, 23.40%
  4. Xanax: 11 people, 23.40%
  5. Zyrtec: 10 people, 21.28%
  6. Pyridium: 10 people, 21.28%
  7. Xopenex Hfa: 10 people, 21.28%
  8. Nitrostat: 10 people, 21.28%
  9. Ultram: 10 people, 21.28%
  10. Xopenex: 9 people, 19.15%

Common side effects people have besides Trigeminal neuralgia *:

  1. Body Height Decreased: 15 people, 31.91%
  2. Weight Decreased: 13 people, 27.66%
  3. Tooth Disorder (tooth disease): 13 people, 27.66%
  4. Headache (pain in head): 13 people, 27.66%
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 12 people, 25.53%
  6. Dizziness: 11 people, 23.40%
  7. Disease Progression: 11 people, 23.40%
  8. Speech Disorder: 11 people, 23.40%
  9. Heart Attack: 11 people, 23.40%
  10. Lip Swelling: 10 people, 21.28%

Common conditions people have *:

  1. Pain: 16 people, 34.04%
  2. Cardiac Disorder: 11 people, 23.40%
  3. Chest Pain: 10 people, 21.28%
  4. Abdominal Discomfort: 8 people, 17.02%
  5. Sensory Disturbance (sense disturbance): 8 people, 17.02%
  6. Hypersensitivity: 8 people, 17.02%
  7. Cerebral Disorder (brain disease): 7 people, 14.89%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 10.64%
  9. Immunodeficiency Common Variable: 5 people, 10.64%
  10. Joint Pain: 5 people, 10.64%

* Approximation only. Some reports may have incomplete information.

Do you take Symbicort and have Trigeminal neuralgia?

Check whether Trigeminal neuralgia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Trigeminal neuralgia and when was it recovered:

Expand to all the drugs that have ingredients of budesonide; formoterol fumarate dihydrate:

Alternative drugs to, pros and cons of Symbicort:

Common Symbicort side effects:

Browse all side effects of Symbicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Trigeminal neuralgia treatments and more:

COVID vaccines that are related to Trigeminal neuralgia:

Common drugs associated with Trigeminal neuralgia:

All the drugs that are associated with Trigeminal neuralgia:

Common conditions associated with Trigeminal neuralgia:

All the conditions that are associated with Trigeminal neuralgia:

How the study uses the data?

The study uses data from the FDA. It is based on budesonide; formoterol fumarate dihydrate (the active ingredients of Symbicort) and Symbicort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: